title: ZK98299, a novel antiprogesterone that does not interact with chicken oviduct progesterone receptor.
abstract: Steroid antagonists, at receptor level, are valuable tools for elucidating the mechanism of steroid hormone action. We have examined and compared the interaction of avian and mammalian progesterone receptors with progestins; progesterone and R5020, and a newly synthesized antiprogesterone ZK98299. In the chicken oviduct cytosol, [3H]R5020 binding to macromolecule(s) could be eliminated with prior incubation of cytosol with excess radioinert steroids progesterone or R5020 but not ZK98299. Alternatively, [3H]ZK98299 binding in the chicken oviduct was not abolished in the presence of excess progesterone, R5020, or ZK98299. In the calf uterine cytosol, [3H]R5020 or [3H]ZK98299 binding was competeable with progesterone, R5020 and ZK98299 but not estradiol, DHT or cortisol. Furthermore, immunoprecipitation and protein A-Sepharose adsorption analysis revealed that in the calf uterine cytosol, the [3H]R5020-receptor complexes were recognized by anti-progesterone receptor monoclonal antibody PR6. This antibody, however, did not recognize [3H]ZK98299-receptor complexes. When phosphorylation of progesterone receptor was attempted in the chicken oviduct mince, presence of progesterone resulted in an increased phosphorylation of the known components A (79 kDa) and B (110 kDa) receptor proteins. Presence of ZK98299 neither enhanced the extent of phosphorylation of A and B proteins nor did it reverse the progesterone-dependent increase in the phosphorylation. The avian progesterone receptor, therefore, has unique steroid binding site(s) that exclude(s) interaction with ZK98299. The lack of immunorecognition of calf uterine [3H]ZK98299-receptor complexes, suggests that ZK98299 is either interacting with macromolecule(s) other than the progesterone receptor or with another site on the same protein. Alternatively, the antisteroid binds to the R5020 binding site but the complex adopts a conformation that is not recognized by the PRG antibodies.
authors.affiliation: Department of Biological Sciences, Oakland University, Rochester, MI 48309-4401.
authors.forename: V K
authors.initials: VK
authors.lastname: Moudgil
authors.forename: R
authors.initials: R
authors.lastname: Nath
authors.forename: A
authors.initials: A
authors.lastname: Bhakta
authors.forename: M
authors.initials: M
authors.lastname: Nakao
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D002417:Cattle; D002645:Chickens; D003600:Cytosol / Q000378:metabolism; D005260:Female; D006067:Gonanes / Q000494:pharmacology*; D066298:In Vitro Techniques; D015735:Mifepristone / Q000494:pharmacology; D015394:Molecular Structure; D010057:Oviducts; D010766:Phosphorylation; D011374:Progesterone / Q000037:antagonists & inhibitors*; D011980:Receptors, Progesterone / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D014599:Uterus / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D006067:Gonanes; D011980:Receptors, Progesterone; D015735:Mifepristone; D011374:Progesterone; C053238:onapristone